Layla Soroush

Array ( [id] => 5585959 [patent_doc_number] => 20090105161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'D-mannose contraceptives' [patent_app_type] => utility [patent_app_number] => 12/292816 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2400 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105161.pdf [firstpage_image] =>[orig_patent_app_number] => 12292816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944957 [patent_doc_number] => 20110105577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Method For Reducing Mycotoxin Contamination In Maize' [patent_app_type] => utility [patent_app_number] => 12/745450 [patent_app_country] => US [patent_app_date] => 2008-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25679 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105577.pdf [firstpage_image] =>[orig_patent_app_number] => 12745450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401704 [patent_doc_number] => 20100305098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/739334 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18784 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305098.pdf [firstpage_image] =>[orig_patent_app_number] => 12739334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279380 [patent_doc_number] => 20090131512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Inhibition of type I in IFN production' [patent_app_type] => utility [patent_app_number] => 12/290654 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13237 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131512.pdf [firstpage_image] =>[orig_patent_app_number] => 12290654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265667 [patent_doc_number] => 20090118352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Broad spectrum microbicidal and spermicidal compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/290288 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8255 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118352.pdf [firstpage_image] =>[orig_patent_app_number] => 12290288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350893 [patent_doc_number] => 20100249164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'MODULATION OF SLEEP WITH NR2B RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/740030 [patent_app_country] => US [patent_app_date] => 2008-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7361 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249164.pdf [firstpage_image] =>[orig_patent_app_number] => 12740030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558781 [patent_doc_number] => 20090270358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'PHARMACEUTICAL FORMULATION OF CLAVULANIC ACID' [patent_app_type] => utility [patent_app_number] => 12/258062 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8681 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270358.pdf [firstpage_image] =>[orig_patent_app_number] => 12258062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136303 [patent_doc_number] => 20110009353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'TARGETING CDK4 AND CDK6 IN CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/741884 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 29235 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009353.pdf [firstpage_image] =>[orig_patent_app_number] => 12741884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279259 [patent_doc_number] => 20090131391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'INHIBITOR FOR DIFFERENTIATION OF HEMATOPOIETIC PRECURSOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/210416 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3362 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131391.pdf [firstpage_image] =>[orig_patent_app_number] => 12210416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291062 [patent_doc_number] => 20090023792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS' [patent_app_type] => utility [patent_app_number] => 12/206290 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023792.pdf [firstpage_image] =>[orig_patent_app_number] => 12206290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111106 [patent_doc_number] => 07718185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Inhibitors of melanocyte tyrosinase as topical skin lighteners' [patent_app_type] => utility [patent_app_number] => 12/206334 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19950 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718185.pdf [firstpage_image] =>[orig_patent_app_number] => 12206334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515484 [patent_doc_number] => 20090215791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'NEW THERAPEUTIC USE OF 4-(2-FLUOROPHENYL)-6-METHYL-2-(1-PIPERAZINYL)THIENO[2,3-D]PYRIMIDINE' [patent_app_type] => utility [patent_app_number] => 12/200102 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2005 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215791.pdf [firstpage_image] =>[orig_patent_app_number] => 12200102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545445 [patent_doc_number] => 20090155322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'SELF-TANNING EFFECTS' [patent_app_type] => utility [patent_app_number] => 12/194674 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4301 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155322.pdf [firstpage_image] =>[orig_patent_app_number] => 12194674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375724 [patent_doc_number] => 20100076047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Amorphous 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol phosphate salt' [patent_app_type] => utility [patent_app_number] => 12/229170 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1888 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076047.pdf [firstpage_image] =>[orig_patent_app_number] => 12229170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055709 [patent_doc_number] => 20110112069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PURIN DERIVATIVES FOR USE IN THE TREATMENT OF FAB-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/673176 [patent_app_country] => US [patent_app_date] => 2008-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3522 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112069.pdf [firstpage_image] =>[orig_patent_app_number] => 12673176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932712 [patent_doc_number] => 08492412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Gel containing pirfenidone' [patent_app_type] => utility [patent_app_number] => 12/673304 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 897 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53388 [patent_doc_number] => 07772258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Agent for treatment of allergic eye disease' [patent_app_type] => utility [patent_app_number] => 12/189040 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5802 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772258.pdf [firstpage_image] =>[orig_patent_app_number] => 12189040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954057 [patent_doc_number] => 20110034442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders' [patent_app_type] => utility [patent_app_number] => 12/672429 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9638 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034442.pdf [firstpage_image] =>[orig_patent_app_number] => 12672429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520931 [patent_doc_number] => 20090028912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Materials for Dissolution-Controlled Release' [patent_app_type] => utility [patent_app_number] => 12/180561 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2164 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028912.pdf [firstpage_image] =>[orig_patent_app_number] => 12180561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17161214 [patent_doc_number] => 11147293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-19 [patent_title] => Nutritional composition for increasing milk protein in mammals [patent_app_type] => utility [patent_app_number] => 12/175716 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4774 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12175716 [rel_patent_id] =>[rel_patent_doc_number] =>)